| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $77.6M | +11.4% |
| R&D Expense | $399.5M | -11.4% |
| SG&A Expense | $143.2M | -25.5% |
| Operating Income | -$512.2M | +11.2% |
| Interest Expense | $80.4M | +72.0% |
| Net Income | -$484.7M | +17.4% |
| EPS (Basic) | -$3.26 | +16.4% |
| EPS (Diluted) | -$3.26 | +16.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $376.7M | -4.3% |
| Short-term Investments | $51.6M | -86.9% |
| Current Assets | $548.9M | -38.3% |
| Total Assets | $623.0M | -38.5% |
| Current Liabilities | $121.4M | -10.1% |
| Long-term Debt | $431.0M | +0.1% |
| Total Liabilities | $1.87B | -0.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$419.5M | +15.8% |
| Capital Expenditures | $4.8M | -63.6% |
| Investing Cash Flow | $453.1M | +325.6% |
| Financing Cash Flow | -$13.1M | -101.8% |
| Free Cash Flow | -$424.3M | +17.0% |
| Stockholders' Equity |
| -$1.25B |
| -44.1% |